Evidence map›Paper›PMID 30197759›Full record

ArticleOncotarget2018

miR-193b and miR-30c-1

Theresa Kordaß, Claudia E M Weber, David Eisel, Antonino A Pane, Wolfram Osen, Stefan B Eichmüller

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. miRNA-576-5p promotes endometrial cancer cell growth and metastasis by targeting ZBTB4.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2023
    Article
  5. MicroRNAs affecting the susceptibility of melanoma cells to CD8Clinical and translational medicine · 2023
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. The miRNAs Role in Melanoma and in Its Resistance to Therapy.International journal of molecular sciences · 2020
    Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Theresa KordaßGMP and T Cell Therapy Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Claudia E M WeberGMP and T Cell Therapy Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.
David EiselGMP and T Cell Therapy Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Antonino A PaneGMP and T Cell Therapy Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Wolfram OsenGMP and T Cell Therapy Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Stefan B EichmüllerGMP and T Cell Therapy Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.
German Cancer Research Center · DEHeidelberg University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In cancer cells, microRNAs (miRNAs) are often aberrantly expressed resulting in impaired mRNA translation. In this study we show that miR-193b and miR-30c-1

Indexed as

BCL9invasionMCL1melanomamiRNA

Identifiers

PMID30197759
PMCPMC6126698
OpenAlexW2888192270

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.